Results 41 to 50 of about 2,566,126 (291)

Stability, Fairness and Random Walks in the Bargaining Problem

open access: yes, 2017
We study the classical bargaining problem and its two canonical solutions, (Nash and Kalai-Smorodinsky), from a novel point of view: we ask for stability of the solution if both players are able distort the underlying bargaining process by reference to a
Kapeller, Jakob, Steinerberger, Stefan
core   +1 more source

The chilling effect and the most ancient form of vengeance:discrimination and victimising third parties [PDF]

open access: yes, 2011
The recent Equality Act 2010 includes a revised definition of “victimisation”, which (in the Act’s most litigated field of employment) prohibits employers from victimising workers who use the legislation.
Connolly, Michael
core   +2 more sources

Strength through diversity: how cancers thrive when clones cooperate

open access: yesMolecular Oncology, EarlyView.
Intratumor heterogeneity can offer direct benefits to the tumor through cooperation between different clones. In this review, Kuiken et al. discuss existing evidence for clonal cooperativity to identify overarching principles, and highlight how novel technological developments could address remaining open questions.
Marije C. Kuiken   +3 more
wiley   +1 more source

Workmen’s Compensation Insurer as Suable Third Party [PDF]

open access: yes, 1969
Until 1960, lawyers appeared to assume that the workmen\u27s compensation insurance carrier partook of the employer\u27s immunity to common law suit by an injured employee.
Larson, Arthur
core   +1 more source

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

open access: yesMolecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg   +43 more
wiley   +1 more source

Control What You Include! Server-Side Protection against Third Party Web Tracking [PDF]

open access: yes, 2017
Third party tracking is the practice by which third parties recognize users accross different websites as they browse the web. Recent studies show that 90% of websites contain third party content that is tracking its users across the web.
Bielova, Nataliia   +2 more
core   +4 more sources

Third-Party Funding in International Investment Arbitration

open access: yesPublic and Private International Law Bulletin, 2022
The use of third-party funding in international investment arbitration has increased significantly in recent years. In thirdparty funding, funders finance a legal claim in which they have no pre-existing interest with the aim of receiving financial ...
Adnan Tarık Doğan
doaj   +1 more source

Post‐COVID Fatigue Is Associated With Reduced Cortical Thickness After Hospitalization

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neuropsychiatric symptoms are among the most prevalent sequelae of COVID‐19, particularly among hospitalized patients. Recent research has identified volumetric brain changes associated with COVID‐19. However, it currently remains poorly understood how brain changes relate to post‐COVID fatigue and cognitive deficits.
Tim J. Hartung   +190 more
wiley   +1 more source

The Role of Ethics in the Development of Arbitration Clauses Towards Third Parties in Iran [PDF]

open access: yesInternational Journal of Ethics and Society, 2023
Introduction: The issue of developing arbitration on persons other than parties to the arbitration is one of the issues that are disputed by legal scholars.
Sara Malek Mohammadi   +2 more
doaj  

Applying an Ethical Lens to the Treatment of People With Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT The practice of neurology requires an understanding of clinical ethics for decision‐making. In multiple sclerosis (MS) care, there are a wide range of ethical considerations that may arise. These involve shared decision‐making around selection of a disease‐modifying therapy (DMT), risks and benefits of well‐studied medications in comparison to
Methma Udawatta, Farrah J. Mateen
wiley   +1 more source

Home - About - Disclaimer - Privacy